| Thrombotic Microangiopathy and the Kidney |
36 |
| Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome |
31 |
| Quality Improvement Goals for Acute Kidney Injury |
26 |
| Patient and Caregiver Priorities for Outcomes in Peritoneal Dialysis Multinational Nominal Group Technique Study |
25 |
| The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors |
23 |
| Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access |
22 |
| Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia A 12-Month Phase 3 Study |
22 |
| Donor-Specific Antibodies in Kidney Transplant Recipients |
21 |
| Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS |
21 |
| Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor |
21 |
| Clinical Pharmacokinetics in Kidney Disease Fundamental Principles |
20 |
| Perfluorinated Chemicals as Emerging Environmental Threats to Kidney Health A Scoping Review |
20 |
| Plant-Based Diets and Incident CKD and Kidney Function |
19 |
| Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy |
18 |
| Clinical Pharmacology in Diuretic Use |
18 |
| Symptom Prioritization among Adults Receiving In-Center Hemodialysis: A Mixed Methods Study |
17 |
| Mechanisms, Clinical Implications, and Treatment of Intradialytic Hypotension |
17 |
| Acute Kidney Injury and Risk of Heart Failure and Atherosclerotic Events |
17 |
| Pharmacology behind Common Drug Nephrotoxicities |
17 |
| ABO-Incompatible Kidney Transplant Outcomes A Meta-Analysis |
17 |
| Effects of Molidustat in the Treatment of Anemia in CKD |
17 |
| Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial |
16 |
| Effects of Dapagliflozin on Circulating Markers of Phosphate Homeostasis |
16 |
| Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure |
16 |
| Parathyroidectomy in the Management of Secondary Hyperparathyroidism |
16 |
| Opioid Analgesics and Adverse Outcomes among Hemodialysis Patients |
15 |
| Changes in Excess Mortality from End Stage Renal Disease in the United States from 1995 to 2013 |
15 |
| Drug Coated Balloon Angioplasty in Failing AV Fistulas: A Randomized Controlled Trial |
15 |
| High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy |
15 |
| Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy: A Case Series |
14 |
| Dementia, Alzheimer's Disease, and Mortality after Hemodialysis Initiation |
14 |
| The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects with End Stage Kidney Disease A Randomized, Controlled Clinical Trial |
14 |
| Medication Safety Principles and Practice in CKD |
14 |
| Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT |
14 |
| Secular Trends in Infection-Related Mortality after Kidney Transplantation |
13 |
| Acute Kidney Injury among Hospitalized Children in China |
13 |
| Healthy Dietary Patterns and Incidence of CKD A Meta-Analysis of Cohort Studies |
13 |
| Neurocognitive and Educational Outcomes in Children and Adolescents with CKD A Systematic Review and Meta-Analysis |
13 |
| An International Analysis of Dialysis Services Reimbursement |
13 |
| Clinical Trial End Points for Hemodialysis Vascular Access Background, Rationale, and Definitions |
13 |
| Nephrotoxicity and Chinese Herbal Medicine |
13 |
| An Outcomes-Based Definition of Proteinuria Remission in Focal Segmental Glomerulosclerosis |
13 |
| Fruit and Vegetable Intake and Mortality in Adults undergoing Maintenance Hemodialysis |
12 |
| Associations between Hemodialysis Facility Practices to Manage Fluid Volume and Intradialytic Hypotension and Patient Outcomes |
12 |
| Kidney Biopsy-Related Complications in Hospitalized Patients with Acute Kidney Disease |
12 |
| Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation |
12 |
| Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease |
12 |
| Characteristics of Colon-Derived Uremic Solutes |
12 |
| Evolution Over Time of Volume Status and PD-Related Practice Patterns in an Incident Peritoneal Dialysis Cohort |
12 |
| Blood Microbiome Profile in CKD: A Pilot Study |
12 |
